Location History:
- Milan, IT (2010 - 2011)
- Rozzano, IT (2022)
Company Filing History:
Years Active: 2010-2022
Title: Barbara Bottazzi: Innovator in Biomedical Research
Introduction
Barbara Bottazzi is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies and pharmaceutical compositions. With a total of 3 patents to her name, Bottazzi's work has the potential to impact various medical applications.
Latest Patents
One of her latest patents is titled "Anti-human migration stimulating factor (MSF) and uses thereof." This invention refers to an antibody that can recognize and bind to an epitope within a sequence of human Migration Stimulating Factor (MSF), while not recognizing human Fibronectin 1 (hFn1). This innovation has implications for diagnostic methods and therapeutic applications. Another notable patent involves "Pharmaceutical compositions containing the long pentraxin PTX3." This patent describes compositions that include human PTX3 for the treatment of infectious, inflammatory, or tumor diseases. It also covers expression vectors containing cDNA coding for PTX3 and methods for producing substantial amounts of PTX3 through cultured recombinant host cells.
Career Highlights
Throughout her career, Bottazzi has worked with reputable companies such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Humanitas Mirasole S.p.a. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative medical solutions.
Collaborations
Bottazzi has collaborated with notable figures in the field, including Alberto Mantovani and Martino Introna. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Barbara Bottazzi is a distinguished inventor whose work in biomedical research continues to pave the way for advancements in therapeutic applications. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific discovery.